Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Details)

v3.22.2.2
NET LOSS PER SHARE (Details)
9 Months Ended
Sep. 30, 2022
shares
Warrant  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Potentially dilutive shares 4,215,080
Stock Options  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Potentially dilutive shares 2,467,500